-
EP3929196
European procedure
Extract from the Register of European Patents
EP About this file: EP3929196
| EP3929196 - PHARMACEUTICAL COMPOSITION OF A NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF [Right-click to bookmark this link] | |||
| Former [2021/52] | NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | ||
| [2022/26] | Status | No opposition filed within time limit Status updated on 27.06.2024 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 21.07.2023 | ||
| Former | Grant of patent is intended Status updated on 06.03.2023 | ||
| Former | Request for examination was made Status updated on 24.02.2023 | ||
| Former | Grant of patent is intended Status updated on 14.12.2022 | ||
| Former | Request for examination was made Status updated on 14.11.2022 | ||
| Former | Grant of patent is intended Status updated on 04.07.2022 | ||
| Former | Request for examination was made Status updated on 26.11.2021 | Most recent event Tooltip | 27.06.2024 | No opposition filed within time limit | published on 31.07.2024 [2024/31] | Applicant(s) | For all designated states FUJIFILM Corporation 26-30, Nishiazabu 2-chome Minato-ku Tokyo 106-8620 / JP | For all designated states PDRadiopharma Inc. 14-1, Kyobashi 2-chome, Chuo-ku Tokyo 104-0031 / JP | [2022/29] |
| Former [2021/52] | For all designated states FUJIFILM Corporation 26-30, Nishiazabu 2-chome Minato-ku Tokyo 106-8620 / JP | ||
| For all designated states FUJIFILM Toyama Chemical Co., Ltd. 14-1, Kyobashi 2-Chome Chuo-Ku Tokyo / JP | Inventor(s) | 01 /
Fukunaga, Hirofumi Kanagawa, 258-8577 / JP | 02 /
Dozono, Hiroyuki Chiba, 289-1592 / JP | 03 /
Hino, Akihiro Chiba, 289-1592 / JP | 04 /
Oshikiri, Shinobu Chiba, 289-1592 / JP | 05 /
Nagano, Akio Chiba, 289-1592 / JP | [2022/07] |
| Former [2021/52] | 01 /
Fukunaga, Hirofumi Kanagawa, 258-8577 / JP | ||
| 02 /
Dozono, Hiroyuki Chiba, 289-1592 / JP | |||
| 03 /
Hino, Akihiro Chiba, 289-1595 / JP | |||
| 04 /
Oshikiri, Shinobu Chiba, 289-1592 / JP | |||
| 05 /
Nagano, Akio Chiba, 289-1592 / JP | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2021/52] | Application number, filing date | 21187649.5 | 24.09.2014 | [2021/52] | Priority number, date | JP20130196712 | 24.09.2013 Original published format: JP 2013196712 | [2021/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3929196 | Date: | 29.12.2021 | Language: | EN | [2021/52] | Type: | B1 Patent specification | No.: | EP3929196 | Date: | 23.08.2023 | Language: | EN | [2023/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 30.08.2021 | Classification | IPC: | C07D471/04, C07D401/12, C07D401/14, C07D519/00, C07K5/062, A61K31/555, A61K51/04, A61P35/00, A61P9/00, C07D213/73, C07D213/75 | [2021/52] | CPC: |
C07D401/12 (EP,US);
A61K51/088 (US);
A61K51/0455 (EP,US);
A61K51/0478 (EP,US);
A61K51/0482 (EP,US);
A61P35/00 (EP);
A61P9/00 (EP);
C07D213/73 (EP,US);
C07D213/75 (EP,US);
C07D401/14 (EP,US);
C07D471/04 (EP,US);
C07D519/00 (EP,US);
C07K5/08 (US);
C07K5/10 (US);
C07K5/0606 (EP,US);
Y02P20/55 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/52] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG VON STICKSTOFFHALTIGE VERBINDUNG ODER SALZ DAVON ODER METALLKOMPLEX DAVON | [2022/26] | English: | PHARMACEUTICAL COMPOSITION OF A NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | [2022/26] | French: | COMPOSITION PHARMACEUTIQUE D'UN COMPOSÉ CONTENANT DE L'AZOTE OU SON SEL OU SON COMPLEXE MÉTALLIQUE | [2022/26] |
| Former [2021/52] | NEUARTIGE STICKSTOFFHALTIGE VERBINDUNG ODER SALZ DAVON ODER METALLKOMPLEX DAVON | ||
| Former [2021/52] | NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | ||
| Former [2021/52] | NOUVEAU COMPOSÉ CONTENANT DE L'AZOTE OU SON SEL OU SON COMPLEXE MÉTALLIQUE | Examination procedure | 26.07.2021 | Examination requested [2021/52] | 19.05.2022 | Amendment by applicant (claims and/or description) | 05.07.2022 | Communication of intention to grant the patent | 11.11.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 15.12.2022 | Communication of intention to grant the patent | 23.02.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 07.03.2023 | Communication of intention to grant the patent | 14.07.2023 | Fee for grant paid | 14.07.2023 | Fee for publishing/printing paid | 14.07.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP14849898.3 / EP3050878 | Divisional application(s) | EP23188351.3 / EP4249471 | Opposition(s) | 24.05.2024 | No opposition filed within time limit [2024/31] | Fees paid | Renewal fee | 26.07.2021 | Renewal fee patent year 03 | 26.07.2021 | Renewal fee patent year 04 | 26.07.2021 | Renewal fee patent year 05 | 26.07.2021 | Renewal fee patent year 06 | 26.07.2021 | Renewal fee patent year 07 | 26.07.2021 | Renewal fee patent year 08 | 19.09.2022 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 23.08.2023 | SM | 23.08.2023 | [2024/28] |
| Former [2024/20] | SM | 23.08.2023 | Documents cited: | Search | [A]WO0035488 (DU PONT PHARM CO [US]); | [A]WO0198294 (DU PONT PHARM CO [US]); | [A]US2005154185 (RAJOPADHYE MILIND [US], et al) | by applicant | US6001961 | US6130231 | US2001053853 | JP2002532440 | US2002169200 | WO2011149250 | WO2013048996 | JP5388355B |